Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges.
about
(4R,6S)-2-Dihydromenisdaurilide is a Butenolide that Efficiently Inhibits Hepatitis C Virus EntryRisk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysisCost-Effectiveness and Cost Thresholds of Generic and Brand Drugs in a National Chronic Hepatitis B Treatment Program in ChinaA review on antibacterial, antiviral, and antifungal activity of curcumin.Prevalence of hepatitis B and C infection in persons living with HIV enrolled in care in Rwanda.Hepatitis B virus: where do we stand and what is the next step for eradication?Current and Future Burden of Chronic Nonmalignant Liver DiseaseHBsAg seroprevalence among Senegalese militaries.Hepatitis B virus epidemiology.Limited Genetic Diversity of Hepatitis B Virus in the General Population of the Offin River Valley in GhanaDisparate distribution of hepatitis B virus genotypes in four sub-Saharan African countries.Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients With Circulating CryoglobulinsThe natural history of recent hepatitis C virus infection among blood donors and injection drug users in the country of Georgia.Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literature.Screening and diagnosis of HBV in low-income and middle-income countries.[Private companies: an opportunity for hepatitis B virus (HBV) prevention and care in Ivory Coast in the wake of HIV/AIDS?].High rate of Hepatitis B virus infection among hairdressers in Ibadan, Nigeria.Implementation of an in-house quantitative real-time polymerase chain reaction method for Hepatitis B virus quantification in West African countries.Hepatitis B virus infection as a neglected tropical disease.A plant-derived dehydrorotenoid: a new inhibitor of hepatitis C virus entry.The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testing.HIV, HBV and HCV prevalence among high risk populations in South India.Seroprevalence of hepatitis B surface antigen (HBsAg) in Bo, Sierra Leone, 2012-2013.Approaches for simplified HCV diagnostic algorithms.Novel strategies in vaccine design: can nanocapsules help prevent and treat hepatitis B?Reduced Incidence and Better Liver Disease Outcomes among Chronic HCV Infected Patients Who Consume CannabisInsights into the Interplay between KIR Gene Frequencies and Chronic HBV Infection in Burkina FasoHighlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and accessUpdate on global epidemiology of viral hepatitis and preventive strategies
P2860
Q27468939-E1FBC144-4A05-4F34-BF7A-6B03AF971D95Q28076352-DCF03667-3325-4E01-AED4-02D77CCB81FBQ28550643-91CB6CF8-D209-4D2A-8289-2946CDB6118EQ33616554-CE8D1B35-8519-4C52-92E8-844D66AE8384Q33630346-09C71381-CFDA-46FE-B84E-5669F23947ADQ33958764-E72D0E1F-5D09-4773-B599-4EEA4BD9BC84Q34490300-EFED60F5-DDA8-4553-94A4-BDA41141CB41Q35633801-533080E7-16EA-4F3A-B3AE-BCF05F33F3ACQ35663834-903DB65E-0DCB-4F0A-B997-44F17A08A224Q36043480-9B00949E-5935-416D-A6F1-969604AA96FFQ36112876-48361CAA-BEE9-463F-A727-41757DC3AAD3Q36194392-BD20238B-528B-4A9C-AA4A-4E82083A6F5CQ36538481-F00A8330-1E39-4F61-A3B6-56D01A80785CQ38793776-33B92622-0551-4925-85FA-4404C7314F18Q38953790-8AC41561-FAFD-462D-8F26-8488AE6F8D28Q39198602-7FC9885B-FCEA-4673-AA0F-1E7D332D9E9AQ40285362-91821A62-8DFD-455C-9C0E-DE0489FE0642Q40471393-77665E11-A524-47DC-89AE-96F466A5FD4AQ41923691-A2918B14-1447-4637-83E2-C391FCFE4A6DQ41981846-3C004743-3081-47C9-90D0-50F7C07CA085Q46490867-B8F7BAC4-4833-4AE8-BA09-9AE2DCEFD85DQ46817716-5BFA41A1-966C-44BD-A97F-739A82CA6E0AQ50109193-3D0B87BD-825D-4B64-97CC-DAAFF1053F2CQ52597014-E24945C5-8E2B-48C2-8BB6-39662E78A16DQ53285668-79DEA539-E363-462E-926E-06B75458573AQ57821728-8BDF30C1-FBFB-4E7A-A562-619771A3B0FDQ58701109-20770830-C0DD-4859-99AB-8663EAC12A14Q58862428-BE5742EF-E957-4D50-871B-C3452C9B670FQ59133434-D67BCC49-1778-4759-9C48-7E6552A108FB
P2860
Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Viral hepatitis in resource-li ...... current and future challenges.
@en
type
label
Viral hepatitis in resource-li ...... current and future challenges.
@en
prefLabel
Viral hepatitis in resource-li ...... current and future challenges.
@en
P2860
P356
P1433
P1476
Viral hepatitis in resource-li ...... current and future challenges
@en
P2093
Maud Lemoine
P2860
P304
P356
10.2217/FVL.13.11
P577
2013-04-01T00:00:00Z